Executive SummaryHigh visibility as "most admired firm" and aggressive recruiting efforts are drawing resumes to Merck in droves. The firm is reputed to have received up to a quarter of a million applications for jobs in 1989. Total employment at the firm grew by a new 2,400 positions in 1989 (7.5%) to 34,400 from 32,000 at the end of 1988.
You may also be interested in...
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of PFS targets in the pancreatic setting.
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.